Xeljanz Stroke Lawsuit Filed Against Pfizer for Gross Negligence in Failing to Warn About Drug Risks
The Xeljanz stroke lawsuit claims the drug's side effects caused a Kentucky woman to temporarily lose control of the right side of her body.
The Xeljanz stroke lawsuit claims the drug's side effects caused a Kentucky woman to temporarily lose control of the right side of her body.
Similar nitrosamine contamination has led to massive Zantac, Chantix, valsartan and metformin recalls in recent years.
Patients with recalled Accuretic pills are being told to continue taking the drug until advised otherwise by a healthcare provider.
The first Nexium bellwether lawsuit is scheduled to go before a jury in October
Pfizer allegedly knew about the blood clot risks with Xeljanz, but misled patients and the medical community in order to maximize profits.
More than 13,000 Nexium lawsuits, Prilosec lawsuits, Protonix lawsuits and other complaints involving kidney side effects from proton pump inhibitor (PPI) heartburn drugs are pending throughout the federal court system.
The move comes after the FDA held up Rinvoq approvals for months due to concerns it carried similar cancer and heart risks as Xeljanz.
The approvals come after new warnings about Xeljanz and Rinvoq side effects, which have been linked to cancer, blood clots and heart problems.
Cancer and heart risks linked to Rinvoq, Xeljanz and similar drugs have regulated them to secondary treatment options for rheumatoid arthritis.
Lawsuits claim the presence of nitrosamines make Chantix an adulterated drug never approved by the FDA.